LENZ   $27.99  6.34% Market Closed After Close 27.99 0.0

LENZ Therapeutics Inc
Total Cash 196.11M
totalCashPerShare 7.132
EBITDA -75.26M
Total Debt 1.70M
quickRatio 22.849
currentRatio 23.226
Total Revenue
debtToEquity 0.882
Revenue/Share
ROA
ROE
grossProfits
freeCashflow
operatingCashflow -73.79M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 554.87M
forwardPE -10.321969
floatShares 12.51M
sharesOutstanding 27.50M
sharesShort 1.95M
sharesShortPriorMonth 1.98M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.86%
Short Ratio help_outline 13.62%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 7.464
Price To Book help_outline 3.65
earningsQuarterlyGrowth
netIncomeToCommon -69.47M
trailingEps -2.74%
forwardEps -2.64%
enterpriseToEbitda -7.37
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.46 3Q 2024
institutionsCount 106
lastUpdated Oct. 17, 2024, 4:29 p.m.